Generate Biomedicines
Trade Generate Biomedicines 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About GENB
Generate Biomedicines, Inc. is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company was founded in 2018, and is headquartered in Somerville, MA.
GENB Key Statistics
Stock Snapshot
The current Generate Biomedicines(GENB) stock price is $15.27, with a market capitalization of 1.96B.
On 2026-09-01, Generate Biomedicines(GENB) stock moved within a range of $14.77 to $15.63. With shares now at $15.27, the stock is trading +3.4% above its intraday low and -2.3% below the session's peak.
Trading volume for Generate Biomedicines(GENB) stock has reached 1.55M, versus its average volume of 2.16M.
Over the past 52 weeks, Generate Biomedicines(GENB) stock has traded between a high of $22.67 and a low of $11.00.
Over the past 52 weeks, Generate Biomedicines(GENB) stock has traded between a high of $22.67 and a low of $11.00.
Analyst ratings
100%
of 6 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.